Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iressa in advanced non-nasopharyngeal head and neck carcinoma
NCT00228488Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of gefitinib in head and neck cancer (HNC), sponsored by AstraZeneca. Started Jun 2004; status: completed.
02
Drugs
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT00228488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228488.